# AnPac Bio-Medical Science Co., Ltd. — Form D

AnPac Bio-Medical Science Co., Ltd. of Lishui, F4, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-24. The offering totals $265K, of which $265K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-08-24
- Form: D
- Accession: 0001104659-20-097978
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $265K
- Amount sold: $265K
- Investors: 1
- Date of first sale: 2020-08-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-373961

## Issuer

- Name: AnPac Bio-Medical Science Co., Ltd.
- CIK: 0001786511
- Entity type: Corporation
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Address: 801 BIXING STREET, BIHU COUNTY, Lishui, F4, 323006
- Phone: +86-5782-051-6666

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| Yu Chris | Director | Lishui, F4 |
| Lin Yu | Director | Irvine, CA |
| Sarah Yu | Director | Lishui, F4 |
| Yu Chris | Executive Officer | Lishui, F4 |
| Jiefeng Gu | Executive Officer | Lishui, F4 |
| Edward Tang | Executive Officer | San Mateo, CA |
| Aidong Chen | Director | Lishui, F4 |
| Aidong Chen | Executive Officer | Lishui, F4 |
| Jianhua Shao | Director | Lishui, F4 |
| Jinqiu Tang | Executive Officer | Lishui, F4 |
| Pu Xing | Director | Lishui, F4 |
| Chris Chang Yu | Director | Lishui, F4 |
| Chris Chang Yu | Executive Officer | Lishui, F4 |
| He Yu | Executive Officer | Lishui, F4 |
| Ren Luo | Director | Lishui, F4 |
| Feng Guo | Director | Lishui, F4 |
| Sheng Liu | Director | Lishui, F4 |
| XueDong Du | Executive Officer | Lishui, F4 |
| Weidong Dai | Executive Officer | Lishui, F4 |
| Chang Yu | Director | Lishui, F4 |
| Chang Yu | Executive Officer | Lishui, F4 |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-06-13](https://search.stillhousedata.com/formd/0001104659-22-070317) | D | $1.5M | $1.5M |
| [2022-06-13](https://search.stillhousedata.com/formd/0001104659-22-070311) | D | $1.5M | $1.5M |
| [2022-05-27](https://search.stillhousedata.com/formd/0001104659-22-065976) | D | $1.4M | $1.4M |

## More

- [CIK 1786511 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1786511&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-20-097978.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.